The question of whether or not "genes" should be eligible for patent protection continues to be a cause of significant tension around the world iri academic, policy and commercial contexts, as well as in the media and other public forums, for wide-ranging reasons. The primary focus of this paper is an analysis of a recent attempt in Australia to use legislative means to exclude from patent eligibility isolated nucleotide and polypeptide sequences (collectively "isolated sequences") that are similar to those that exist in nature.
Funding
Australian Research Council
History
Publication title
Journal of Law and Information Science
Volume
22
Pagination
EAP1-EAP23
ISSN
0729-1485
Department/School
Faculty of Law
Publisher
University of Tasmania Law School
Place of publication
Hobart
Rights statement
Copyright 2012 Journal of Law, Information & Science